# LMZ Team

## Project Title
**Early Detection of Breast Cancer Using Gene Expression Profiling and Machine Learning Approaches**

![Breast Cancer](https://github.com/oladams/FTL_ML4_GROUP1/blob/main/Breast_Cancer.jpeg?raw=true)

---

## Team Members:
1. **Lames Mohamed Ahamed Yousif Salih**  
2. **Moaaz Mohammed Saadaldin Yousif**  
3. **Zongo Thierry**

**Date:** November 2024

---

## Project Overview

Breast cancer remains one of the leading causes of death among women worldwide. Early detection plays a critical role in improving survival rates and enhancing treatment outcomes. This project aims to develop an innovative early detection system for breast cancer by leveraging **gene expression profiling** through **RNA-Seq data**. The primary objective is to identify key biomarkers associated with breast cancer and to employ advanced **machine learning models** to predict cancer diagnoses accurately.

By analyzing complex gene expression patterns, the system seeks to provide a non-invasive and reliable method for early diagnosis, improving patient outcomes and reducing mortality rates.



---

## Relevance to Sustainable Development Goals (SDGs)

This project is aligned with several **Sustainable Development Goals (SDGs)**, focusing on health, equity, and innovation:

- **SDG 3: Good Health and Well-being**  
  The project directly addresses the goal of improving public health by enhancing early cancer detection methods. By using gene expression profiling, the system can contribute to a reduction in mortality rates and improve treatment outcomes through early, accurate diagnosis.

- **SDG 10: Reduced Inequalities**  
  With the development of accessible diagnostic tools, this project can bridge the gap in healthcare, particularly in regions with limited access to advanced medical technologies. It promotes equitable access to quality healthcare services, ensuring that underprivileged populations benefit from innovative diagnostic solutions.

- **SDG 9: Industry, Innovation, and Infrastructure**  
  Utilizing cutting-edge machine learning techniques, this project supports the advancement of healthcare technology and research infrastructure, driving innovation in both the healthcare and technology sectors.

---

## Literature Review

This project builds on foundational research in the fields of genomics and machine learning. Key studies include:

- **Parker, J. S., et al. (2009):**  
  This pivotal study developed a risk predictor based on intrinsic breast cancer subtypes, which improved diagnostic precision and aided in the development of personalized treatment plans.

- **SÃ¸rlie, T., et al. (2001):**  
  The identification of molecular subtypes of breast cancer through gene expression significantly enhanced diagnostic accuracy and provided valuable insights into prognosis prediction.

These studies emphasize the importance of gene expression profiling in cancer research and demonstrate the potential of machine learning to improve cancer detection and prognosis.

---

## Data Description

For this project, we will utilize **RNA-Seq data** sourced from **The Gene Expression Omnibus (GEO)**. The dataset contains gene expression profiles from both breast cancer patients and healthy control subjects. 

Data preprocessing will include:
- **Normalization**: Ensuring data consistency across samples.
- **Imputation of Missing Values**: Addressing incomplete data to avoid model biases.
- **Feature Selection**: Identifying the most relevant features for improved model performance.

These steps are critical for ensuring that the data is clean, high-quality, and suitable for use in developing accurate predictive models.

---

## Methodology: Machine Learning Approach

To achieve the goal of early breast cancer detection, this project will employ **machine learning techniques**, specifically:

- **Random Forest (RF)**  
- **Support Vector Machines (SVM)**  

Both algorithms are well-suited for analyzing complex, high-dimensional gene expression data. **Random Forest** is an ensemble method that excels in handling noisy data, while **Support Vector Machines** are effective in classifying complex datasets with a high degree of accuracy. These methods will allow us to identify biomarkers that are key indicators of breast cancer and classify samples as cancerous or healthy with high precision.

Key stages of the methodology will include:
1. **Preprocessing**: Normalization, missing value imputation, and feature selection.
2. **Model Training**: Implementing RF and SVM algorithms on the preprocessed data.
3. **Evaluation**: Assessing model performance using metrics such as accuracy, precision, recall, and F1-score.

By applying these techniques, we aim to develop a model that can make reliable predictions for early breast cancer detection, which could potentially save lives through timely interventions.

---

## Conclusion

The **Early Detection of Breast Cancer Using Gene Expression Profiling and Machine Learning Approaches** project aims to harness the power of advanced genomics and machine learning to improve cancer detection. By identifying key biomarkers from gene expression data and utilizing machine learning models, we hope to contribute to global health efforts, particularly by providing a scalable and accessible tool for early breast cancer diagnosis. This approach is not only a step forward in precision medicine but also supports broader efforts to reduce health disparities and promote equity in healthcare.

---
